medigraphic.com
ISSN 1729-519X (Print)

2013, Number 4

<< Back Next >>

Revista Habanera de Ciencias Médicas 2013; 12 (4)

Pelvic exenteration in advanced cancer of the vulva. Case presentation

Esperón NRP, Valdés JJM, Montero LJF, Bosque DOJ, Silveira PJM, Linchenat LA

Language: Spanish
References: 30
Page: 618-626
PDF size: 103.95 Kb.


ABSTRACT

Introduction: carcinoma of the vulva is a rare cancer that is between 4 and 5 percent of all gynecologic cancers. The Pelvic exenteration offers one last chance to "cure" some patients with gynecological malignant neoplastic disease, advanced or recurrent. However, the morbidity of radical surgery is high complex.
Objetive: describe the clinical case of a patient studied and treated with a primary squamous cell carcinoma of the vulva.
Case presentation: we describe the clinical characteristics of the patient, the result of the complementary; initial staging, the therapeutic procedure, results of the histopathological study, the postoperative staging, postoperative course, and follow-up data.
Conclusions: postoperative results are satisfactory at 3 years follow-up, there was a single complication: edema of both lower in the first year after the surgery that evolved properly. Currently holds satisfactory for vaginal sex.


REFERENCES

  1. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948; 1:177-83.

  2. Bricker EM, Modlin EJ. The role of pelvic evisceration in surgery. Surgery. 1951; 30:76-94.

  3. Carter J, Chi DS, Abu_Rustum N, Brown CL, McCreath W, Barakat RR. Brief Report: Total Pelvic Exenteration _ A Retrospective Clinical Needs Assessment. Psycho_Oncology. 2004; 13:125-31.

  4. Durgatosh P, Shuaib Z, Vikas M, Ravi K. Pelvic exenteration: A perspective from a regional cancer center in India. Indian J Cancer. 2004; 41(3):109-14.

  5. Lambrou NC, Pearson JM, Averette HE. Pelvic Exenteration of Gynecologic Malignancy: Indications,and Technical and Reconstructive Considerations. Surg Oncol Clin North Am. 2005; 14:289-300.

  6. Benn T, Brooks RA, Zhang Q, Powell MA, Thaker PH, Mutch DG, Zighelboim I. Pelvic exenteration in gynecologic oncology: A single institution study over 20 years. Gynecol Oncol. 2011; 122:14-8.

  7. Mitulescu G, Ungureanu C, Gluck G, Stîngu C, Mitulescu D, Stãnculeanu D, Sgarburã O, et al. Exenteratia pelvinã totalã în tratamentul cancerului pelvin avansat. Chirurgia. 2007; 102 (2):143-154.

  8. Schneider A, Köhler C, Erdemoglu E. Current developments for pelvic exenteration in gynecologic oncology. Curr Opin Obstet Gynecol. 2009; 21(1):4-9.

  9. Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR. Old and new perspectives in the management of high_risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol. 2006; 60:227-41.

  10. Berek J, Howe C, Lagasse L, et al. Pelvic exenteration for recurrent gynaecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol. 2005;99:153-59.

  11. Marnitz S, Dowdy S, Lanowska M, Schneider A, Podratz K, Köhler C. Exenterations 60 years after first description: results of a survey among US and German Gynecologic Oncology Centers. Int J Gynecol Cancer. 2009; 19(5):974-7.

  12. Goldberg J, Piver S, Hempling R, et al. Improvement in pelvic exenteration: factors responsible for reducing morbidity and mortality. Ann Surg Oncol. 1998; 5:399-406.

  13. Magrina J, Stanhope C, Waever A. Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol. 1997; 64:130-35.

  14. Vieira SC, Costa DR, Meneses AD, Silva JB, Oliveira AKS, Sousa RB. Exenteração pélvica para câncer do colo uterino recidivado pós-radioterapia: experiência de um centro terciário do Nordeste brasileiro. Rev Bras Ginecol Obstet. 2009; 31(1):22-7.

  15. Morley G, Hopkins M, Lindenauer S, et al. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol. 1989; 74:934-43.

  16. Rutledge F, Smith J, Wharton J, et al. Pelvic exenteration: analysis of 296 patients. Am. J Obstet Gynecol. 1977; 129:881-92.

  17. Sharma S, Odunsi K, Driscoll D, et al. Pelvic exenteration for gynecological malignancies: twenty-year experience at Rosewell Park Cancer Institute. Int J Gynecol Cancer. 2005; 15:475-82.

  18. Shingelton H, Soong S, Gelder M, et al. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol. 1989; 73:1027-34.

  19. Redondo A, Castelo B, Gómez C. Cáncer de vulva y vagina. En: Cortés-Funes H, Colomer R (Eds.) Tratado de Oncología. 2ª Ed. Barcelona: P. Permanyer; 2009. [Edición en CD-ROM].

  20. Roos E, de Graeff A, van Eijkeren M, et al. Quality of live after pelvic exenteration. Gynecol Oncol. 2004; 93:610-14.

  21. Ferenschild FTJ, Vermaas M, Verhoef C, Ansink AC, Kirkels WJ, Eggermont AMM, de Wilt JHW. Total Pelvic Exenteration for Primary and Recurrent Malignancies. World J Surg. 2009; 33:1502-08.

  22. Fotopoulou C, Neumann U, Kraetschell R, Schefold JC, Weidemann H, Werner L., Sehouli J. Long?Term Clinical Outcome of Pelvic Exenteration in Patients with Advanced Gynecological Malignancies. Journal Surg Oncol. 2010; 101:507-12.

  23. Forner DM, Lampe B. Intestinal Complication after Pelvic Exenterations in Gynecologic Oncology. Int J Gynecol Cancer. 2009; 19:958-62.

  24. Moore K, Gold M, McMeekin D, et al. Vesicovaginal fistula formation in patients with stage IVA cervical cancer. Gynecol Oncol.2007; 106:498-501.

  25. Morris M, Eifel P, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999; 340:1137-43.

  26. López H, Morales F, Ochoa E, Ochoa P, Ruiz J. Major complications following exenteration in cases of pelvic malignancy: an 18-year experience. BMC Cancer. 2007; 7(Suppl 1):A37.

  27. Park JY, Choi HJ, Jeong SY, Chung J, Park JK, Park SY. The Role of Pelvic Exenteration and Reconstruction for Treatment of Advanced or Recurrent Gynecologic Malignancies: Analysis of Risk Factors Predicting Recurrence and Survival. Journal of Surgical Oncology. 2007; 96:560-68.

  28. Höckel M, Dornhöfer K. Pelvic exenterations for gynecological tumours: achievements and unanswered questions. Lancet Oncol. 2006;7:837-47.

  29. Höckel M. Laterally extended endopelvic resection—novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall. Gynecol Oncol. 2003; 91:369-77.

  30. Robertson G, Lopes A, Beynon G, Monaghan J. Pelvic exenteration: a review of the Gateshead experience 1974_1992. Br J Obstet Gynecol. 1994; 101:529-31.




2020     |     www.medigraphic.com